Discover trends, market shifts, and competitive outlooks for the head and neck cancer diagnostics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Fast Is The Head And Neck Cancer Diagnostics Market Expected to Grow Between 2025 And 2029?
The market for diagnostics in head and neck cancer has witnessed swift expansion in the recent past. The market value is predicted to rise from $1.74 billion in 2024, to an estimated $2.05 billion in 2025, marking a compound annual growth rate (CAGR) of 17.4%. Factors contributing to this historic growth include rising tobacco and alcohol usage, an increasing elderly population, promotional health campaigns, advancements in biopsy methods, and the development of healthcare infrastructure.
The market for diagnostics of head and neck cancer is projected to witness substantial growth in the forthcoming years, with projections suggesting it will reach $3.87 billion in 2029, expanding at a compound annual growth rate (CAGR) of 17.3%. The predicted growth during the forecasted era can be credited to elements like genomic biomarkers, the surge in cases of HPV-related cancers, amalgamation of artificial intelligence (AI), targeted therapies and immunotherapy, alteration in healthcare policies and reimbursements. Significant trends for the forecast period encompass dominance of liquid biopsy, multi-modality diagnostics, point-of-care diagnostics, international collaborations and partnerships, and incorporation of digital pathology.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12016&type=smp
Which Factors and External Forces Are Driving Demand in the Head And Neck Cancer Diagnostics Market?
With the rise in the occurrence of head and neck cancer, the market for its diagnostics is anticipated to grow. Head and neck cancer is characterised by tumors that impact organs and tissues in the head and neck area, which can include the oral cavity, pharynx, larynx, salivary glands, nasal corridor, and sinuses. Performing diagnostic tests, like an incisional biopsy and a barium swallow test can help patients recognize the disease in the earlier stages. As an example, data from the American Society of Clinical Oncology in February 2023 revealed that head and neck cancer constituted 4% of all malignancies in the US, with an expected number of 66,920 individuals (49,190 men and 17,730 women) to be impacted by the disease in the USA in 2023. The disease influenced 562,328 individuals globally in 2020. Further, it was reported that in 2022, Australia had 5,189 new cases of head and neck cancer. As such, the increasing rate of head and neck cancer largely contributes to the expanding head and neck cancer diagnostics market.
Which Segments in the Head And Neck Cancer Diagnostics Offer the Most Growth?
The head and neck cancer diagnostics market covered in this report is segmented –
1) By Diagnostic Method: Diagnostic Imaging Equipment, Endoscopy Screening Equipment, Biopsy Screening Tests, Dental Diagnostic Methods, Other Diagnostic Methods
2) By Channel: Retail And Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies
3) By End-User: Hospitals, Diagnostic Centers, Other End Users
Subsegments:
1) By Diagnostic Imaging Equipment: Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans, X-rays
2) By Endoscopy Screening Equipment: Rigid Endoscopes, Flexible Endoscopes, Video Endoscopy Systems
3) By Biopsy Screening Tests: Fine Needle Aspiration (FNA) Biopsy, Core Needle Biopsy, Surgical Biopsy
4) By Dental Diagnostic Methods: Intraoral Cameras, Dental X-rays, Oral Cancer Screening Devices
5) By Other Diagnostic Methods: Molecular Diagnostics, Blood Tests, Genetic Testing
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12016&type=smp
What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Head And Neck Cancer Diagnostics Market?# Market?
North America was the largest region in the head and neck cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Cutting-Edge Market Trends Are Expected to Drive theHead And Neck Cancer Diagnostics Market’s Growth?
The advent of product innovation has proven to be a significantly rising trend in the head and neck cancer diagnostic market. The prominent players in the market are heavily investing in developing creative products to solidify their standing in the market. For example, in May 2023, Alkem Laboratories Ltd., a healthcare company based in India, introduced Cetuxa, the first biosimilar in the world for treating head and neck cancer. Cetuxa, akin to cetuximab, is a monoclonal antibody that impedes the receptor-mediated transduction pathway and exhibits anti-tumor characteristics. It binds to the extracellular domain of the epidermal growth factor receptor (EGFR). Typically, cetuximab is used in combination with chemotherapy or radiation therapy in a medical setting. It is potent for addressing locally advanced, reoccurring, or metastatic squamous cell carcinoma of the head and neck.
View the full report here:
What Are the Key Elements That Define the Head And Neck Cancer Diagnostics Market?
Head and neck cancer diagnostics refers to the process of detecting and confirming the presence of malignant cells in the head and neck region by a combination of physical examination, imaging tests, medical history evaluation, and tissue biopsy. It is commonly used to treat squamous cell carcinomas, laryngeal cancer, and hypopharyngeal cancer.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12016
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
